Latest Fludeoxyglucose Stories
BERLIN, November 23, 2010 /PRNewswire-FirstCall/ -- Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), a company specializing in special compounds for the diagnosis and treatment of cancer, via its subsidiary company Eckert & Ziegler f-con Deutschland GmbH closed an exclusive sales agreement with the Karlsruhe-based ZAG Zyklotron AG for the regular delivery of Fluorodeoxyglucose (18F) (FDG).
Scientists at the University of Granada applied successfully a new technique called FDG positron emission tomography scanning, which allows more accurate diagnosis and treatment of Gall bladder cancer.
SAN DIEGO, Aug.
New study suggests that medication used to control blood sugar levels can distort results of some molecular imaging screenings for cancer.
WARRENDALE, Pa., May 19 /PRNewswire/ -- Today, MEDRAD, Inc. and Pinestar Technology, Inc. announced plans to enable data communication between MEDRAD's Intego(TM) PET Infusion System and Pinestar's Nuclear Medicine Information System (NMIS).
Immune cell function in an individual can be monitored noninvasively in the clinic using a technique known as a PET scan.
Early diagnosis and treatment essential for patients with aortic dissections.
Fine-tuning radiotherapy to take into account which parts of a patient's tumor are growing fastest could improve control of cancer while subjecting patients to lower doses of radiation.
SAN DIEGO, March 22 /PRNewswire/ -- Naviscan announced today that Alliance Imaging, a division of Alliance Healthcare Services, will be offering mobile Positron Emission Mammography (PEM) imaging services in the state of Florida.
Scientists from the Kimmel Cancer Center at Jefferson have discovered a possible way for malignant breast tumors to be identified, without the need for a biopsy.
- totally perplexed and mixed up.